|
C18ORF32 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.3265000004844E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.8903000000019E-05 |
| Normal-vs-Stage2 |
5.350700E-04 |
| Normal-vs-Stage3 |
1.48280000000778E-06 |
| Normal-vs-Stage4 |
9.93999999999717E-05 |
| Stage1-vs-Stage2 |
6.994600E-01 |
| Stage1-vs-Stage3 |
1.822470E-02 |
| Stage1-vs-Stage4 |
8.877600E-02 |
| Stage2-vs-Stage3 |
1.236410E-01 |
| Stage2-vs-Stage4 |
1.051590E-01 |
| Stage3-vs-Stage4 |
9.009600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.0047000005039E-07 |
| Normal-vs-AfricanAmerican |
1.519380E-03 |
| Normal-vs-Asian |
9.399500E-04 |
| Caucasian-vs-AfricanAmerican |
2.044000E-01 |
| Caucasian-vs-Asian |
1.738610E-01 |
| AfricanAmerican-vs-Asian |
1.205440E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.47329999977686E-07 |
| Normal-vs-Female |
2.642000E-04 |
| Male-vs-Female |
2.557600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.012500E-04 |
| Normal-vs-Extreme_Weight |
1.51896999999179E-05 |
| Normal-vs-Obese |
4.07490000000621E-05 |
| Normal-vs-Extreme_Obese |
6.422200E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.332000E-01 |
| Normal_Weight-vs-Obese |
4.157800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.404200E-01 |
| Extreme_Weight-vs-Obese |
7.545000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.545000E-01 |
| Obese-vs-Extreme_Obese |
2.236800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.195400E-04 |
| Normal-vs-Age(41-60Yrs) |
4.19009999996778E-06 |
| Normal-vs-Age(61-80Yrs) |
1.56459999999248E-05 |
| Normal-vs-Age(81-100Yrs) |
1.282700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.415000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.025600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.177000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.960200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.405400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.965800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.17619999995267E-06 |
| Normal-VS-Type2 PRCC |
1.70469999999368E-05 |
| Normal-VS-KIRP CIMP |
1.604830E-04 |
| Normal-VS-Unclassified PRCC |
1.10559999999538E-06 |
| Type1 PRCC-VS-Type2 PRCC |
3.087600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.007440E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.154400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.264800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.823200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.171000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.54300000005026E-06 |
| Normal-vs-N1 |
1.08769999673797E-08 |
| Normal-vs-N2 |
4.119000E-03 |
| N0-vs-N1 |
2.890100E-02 |
| N0-vs-N2 |
3.215400E-01 |
| N1-vs-N2 |
9.970000E-01 |
|
|
